[HTML] sciencedirect.com

[HTML][HTML] Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis

M Seretny, GL Currie, ES Sena, S Ramnarine, R Grant… - Pain®, 2014 - Elsevier
Chemotherapy-induced peripheral neuropathy (CIPN) is a disabling pain condition resulting
from chemotherapy for cancer. Severe acute CIPN may require chemotherapy dose …
被引用次数：1428 相关文章
[PDF] psu.edu

[PDF][PDF] Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis

M Seretny, GL Currie, ES Sena, S Ramnarine, R Grant… - PAIN, 2014 - Citeseer
abstract Chemotherapy-induced peripheral neuropathy (CIPN) is a disabling pain condition
resulting from chemotherapy for cancer. Severe acute CIPN may require chemotherapy …

CN-16INCIDENCE, PREVALENCE AND PREDICTORS OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY: A SYSTEMATIC REVIEW AND META …

M Seretny, G Currie, E Sena, S Ramnarine… - Neuro …, 2014 - ncbi.nlm.nih.gov
BACKGROUND: Chemotherapy Induced Peripheral Neuropathy (CIPN) is a disabling side
effect of chemotherapy. Severe CIPN may require chemotherapy dose reduction or …

Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis

M Seretny, GL Currie, ES Sena, S Ramnarine… - Pain, 2014 - pubmed.ncbi.nlm.nih.gov
Chemotherapy-induced peripheral neuropathy (CIPN) is a disabling pain condition resulting
from chemotherapy for cancer. Severe acute CIPN may require chemotherapy dose …

Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis

M Seretny, GL Currie, ES Sena, S Ramnarine, R Grant… - Pain, 2014 - infona.pl
Chemotherapy-induced peripheral neuropathy (CIPN) is a disabling pain condition resulting
from chemotherapy for cancer. Severe acute CIPN may require chemotherapy dose …

[引用][C] Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis

M Seretny, GL Currie, ES Sena, S Ramnarine, R Grant… - Pain, 2014 - cir.nii.ac.jp
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A
systematic review and meta-analysis | CiNii Research CiNii 国立情報学研究所 学術情報 …

[引用][C] Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis

M SERETNY, GL CURRIE, ES SENA… - Pain …, 2014 - pascal-francis.inist.fr
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A
systematic review and meta-analysis CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Incidence, Prevalence and Predictors of Chemotherapy Induced Peripheral Neuropathy

M Seretny, GL Currie, ES Sena, S Ramnarine… - Pain, 2014 - discovery.dundee.ac.uk
Abstract Chemotherapy Induced Peripheral Neuropathy (CIPN) is a disabling pain condition
resulting from chemotherapy for cancer. Severe acute CIPN may require chemotherapy …
[PDF] core.ac.uk

[PDF][PDF] Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis

M Seretny, GL Currie, ES Sena, S Ramnarine, R Grant… - PAIN, 2014 - core.ac.uk
abstract Chemotherapy-induced peripheral neuropathy (CIPN) is a disabling pain condition
resulting from chemotherapy for cancer. Severe acute CIPN may require chemotherapy …
[PDF] academia.edu

[PDF][PDF] Incidence, Prevalence and Predictors of Chemotherapy Induced Peripheral Neuropathy: a Systematic Review and Meta-Analysis.

M Seretny, GL Currie, ES Sena, S Ramnarine, R Grant… - 2014 - academia.edu
Chemotherapy induced peripheral neuropathy (CIPN) is a disabling side effect of several
commonly used antineoplastic agents. The development of CIPN may require chemotherapy …